Collins: End of Stimulus Funds Could Send NIH Off Cliff in '11 Aug. 18, 2009 By Donna Young No Comments
Seattle Genetics Gets $118.2M for Antibody Conjugate, More Aug. 13, 2009 By Donna Young No Comments In the wake of a stock bump following a $2.4 billion acquisition offer for fellow antibody firm Medarex Inc., Seattle Genetics Inc. is boosting its cash position by $118.2 million through a public stock offering. (BioWorld Today)Read More
